Home » Topics » Regulatory » EMA

EMA
RSS

Merck KGaA to appeal CHMP's opinion on cladribine tablets in MS

Oct. 11, 2010

CHMP recommends variation to terms of marketing authorization for Invega

Oct. 5, 2010

Prefilled syringes of Relistor approved in U.S., E.U. and Canada

Oct. 1, 2010

Novartis' H5N1 vaccine Aflunov for adults gets positive opinion in E.U.

Sep. 29, 2010

CHMP recommends approval of AstraZeneca's ticagrelor

Sep. 29, 2010

CHMP finds no causal relationship between GSK's Pandemrix vaccine and narcolepsy

Sep. 28, 2010

Rosiglitazone-containing diabetes medicines suspended in Europe, restricted in U.S.

Sep. 28, 2010

CHMP recommends approval of TOBI Podhaler for cystic fibrosis

Sep. 28, 2010

CHMP recommends approval of Tasigna in E.U. as first-line therapy for Ph+ CML

Sep. 28, 2010

FDA and EMA to review vandetanib for advanced medullary thyroid cancer

Sep. 27, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...